Registry for neonates, infants, children, adolescents,and adults with newly diagnosed and/or relapsedneuroblastic tumors(NB Registry 2016)
Recruiting
- Conditions
- C74.1Medulla of adrenal gland
- Registration Number
- DRKS00023442
- Lead Sponsor
- K Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Diagnosis or suspicion of neuroblastic tumor in patients either histologically or cytologically proven neuroblastic tumors such as neuroblastoma, ganglioneuroblastoma, and ganglioneuroma (at diagnosis or at
relapse), also suspected neuroblastoma in newborns and infants (e.g. suprarenal lesions) detected at least during two independent ultrasound investigations, any age, any stage, any MYCN status, written Guardians’ informed consent of parents or legal guardians and / or of the patient’s informed consent if appropriate according to age and status of psycho-intellectual development.
Exclusion Criteria
For this registry, no exclusion criteria are defined. Each patient meeting the inclusion criteria given above may be registered.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aims of the registry are the collection of clinical data, to give the frame for reference diagnostics, and the collection of biomaterial.
- Secondary Outcome Measures
Name Time Method not relevant